Methadone Take-Home Policies and Associated Mortality: Permitting versus Non-Permitting States
Open Access
- 1 January 2024
- journal article
- research article
- Published by SAGE Publications in Substance Use: Research and Treatment
- Vol. 18
Abstract
To mitigate COVID-19 exposure risks in methadone clinics, the Substance Abuse and Mental Health Services Administration (SAMHSA) issued a temporary modification of regulations in March 2020 to permit, with state concurrence, extended take-home methadone doses. The modification allowed for up to 28 days of take-home methadone for stable patients and 14 days for those less stable. Using both interrupted time series and difference-in-differences methods, this study examined the association between the policy change and fatal methadone overdoses, comparing states that permitted the expansion of take-home doses with states that did not. The findings suggest the pandemic emergency take-home policy did not increase methadone-involved mortality.Keywords
Funding Information
- National Institute on Drug Abuse (K23 DA054157)
This publication has 13 references indexed in Scilit:
- Comparing methadone policy and practice in France and the US: Implications for US policy reformInternational Journal of Drug Policy, 2024
- Adoption of methadone take home policy by U.S. state opioid treatment authorities during COVID-19International Journal of Drug Policy, 2024
- The impact of relaxing restrictions on take-home doses during the COVID-19 pandemic on program effectiveness and client experiences in opioid agonist treatment: a mixed methods systematic reviewSubstance Abuse Treatment, Prevention, and Policy, 2023
- Examination of methadone involved overdoses during the COVID-19 pandemicForensic Science International, 2023
- Estimating the impact of the COVID-19 pandemic on rising trends in drug overdose mortality in the United States, 2018-2021Annals of Epidemiology, 2022
- Methadone-Involved Overdose Deaths in the US Before and After Federal Policy Changes Expanding Take-Home Methadone Doses From Opioid Treatment ProgramsJAMA Psychiatry, 2022
- Alcohol-Related Deaths During the COVID-19 PandemicJAMA, 2022
- Take-home dosing experiences among persons receiving methadone maintenance treatment during COVID-19Journal of Substance Abuse Treatment, 2021
- Medications for Opioid Use Disorder Save Lives2019
- Difference in difference, controlled interrupted time series and synthetic controlsInternational Journal of Epidemiology, 2019